blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1554572

EP1554572 - COMPOSITIONS AND METHODS FOR MODULATING BLOOD-BRAIN BARRIER TRANSPORT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.08.2010
Database last updated on 16.09.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR
published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
Raptor Pharmaceutical, Inc.
9 Commercial Boulevard, Suite 200
Novato CA 94949 / US
[2010/01]
Former [2006/31]For all designated states
Raptor Pharmaceutical Inc.
P.O. Box 226
Sonoma, CA 95476 / US
Former [2005/29]For all designated states
BioMarin Pharmaceutical Inc.
371 Bel Marin Keys Boulevard, Suite 210
Novato, CA 94949 / US
Inventor(s)01 / BELIVEAU, Richard
266 Wilson
Ile Des Soeurs, Québec / CA
02 / DEMEULE, Michel
343 Preston
Beaconsfield, Quebec H9W 1Z2 / CA
03 / YANG, Joseph
11642 Summit Cresc.
North Delta, British Columbia V4E 2Z5 / CA
04 / KENNARD, Malcolm, L.
2396 Caledonia Ave.
North Vancouver, British Columbia V7G 1T9 / CA
05 / GABATHULER, Reinhardt
97 Rose Street
San Rafael California 94901 / US
 [2009/39]
Former [2005/29]01 / BELIVEAU, Richard
266 Wilson
Ile Des Soeurs, Québec / CA
02 / DEMEULE, Michel
MOntreal, Quebec / CA
03 / YANG, Joseph
11642 Summit Cresc.
North Delta, British Columbia V4E 2Z5 / CA
04 / KENNARD, Malcolm, L.
2396 Caledonia Ave.
North Vancouver, British Columbia V7G 1T / CA
05 / GABATHULER, Reinhardt
97 Rose Street
San Rafael California 94901 / US
Representative(s)Harding, Charles Thomas, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2009/26]Harding, Charles Thomas, et al
D Young & Co 120 Holborn London
EC1N 2DY / GB
Former [2008/24]Harding, Charles Thomas, et al
D Young & Co 120 Holborn
London EC1N 2DY / GB
Former [2006/31]Richards, William John, et al
D Young & Co, 120 Holborn
London EC1N 2DY / GB
Former [2005/29]Richards, William John
D Young & Co, 120 Holborn
London EC1N 2DY / GB
Application number, filing date02756731.225.07.2002
[2005/29]
WO2002US23923
Priority number, dateUS20010308002P25.07.2001         Original published format: US 308002 P
[2005/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03009815
Date:06.02.2003
Language:EN
[2003/06]
Type: A2 Application without search report 
No.:EP1554572
Date:20.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 06.02.2003 takes the place of the publication of the European patent application.
[2005/29]
Type: B1 Patent specification 
No.:EP1554572
Date:14.10.2009
Language:EN
[2009/42]
Search report(s)International search report - published on:US19.05.2005
(Supplementary) European search report - dispatched on:EP09.02.2006
ClassificationIPC:G01N33/50, G01N33/567
[2006/13]
CPC:
A61K38/40 (EP,US); A61K38/177 (EP,US); A61K47/644 (EP,US);
A61P25/00 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/28 (EP); A61P35/00 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/10 (EP); C07K16/40 (EP,US);
A61K2039/505 (EP,US) (-)
Former IPC [2005/29]G01N33/50, G01N33/566, G01N33/567
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2005/29]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION DES TRANSPORTS DURCH DIE BLUT-HIRN-SCHRANKE[2005/29]
English:COMPOSITIONS AND METHODS FOR MODULATING BLOOD-BRAIN BARRIER TRANSPORT[2005/29]
French:COMPOSITIONS ET PROCEDES DE MODULATION DU TRANSPORT A TRAVERS LA BARRIERE HEMATHO-ENCEPHALIQUE[2005/29]
Entry into regional phase24.12.2003National basic fee paid 
24.12.2003Search fee paid 
24.12.2003Designation fee(s) paid 
24.12.2003Examination fee paid 
Examination procedure25.02.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
24.12.2003Examination requested  [2005/29]
15.09.2006Despatch of a communication from the examining division (Time limit: M06)
14.03.2007Reply to a communication from the examining division
22.05.2007Despatch of a communication from the examining division (Time limit: M06)
11.10.2007Reply to a communication from the examining division
08.10.2008Date of oral proceedings
14.10.2008Despatch of a communication from the examining division (Time limit: M02)
14.10.2008Minutes of oral proceedings despatched
19.12.2008Reply to a communication from the examining division
27.04.2009Communication of intention to grant the patent
21.08.2009Fee for grant paid
21.08.2009Fee for publishing/printing paid
Divisional application(s)EP09012753.1  / EP2147679
Opposition(s)15.07.2010No opposition filed within time limit [2010/38]
Fees paidRenewal fee
14.07.2004Renewal fee patent year 03
20.07.2005Renewal fee patent year 04
12.07.2006Renewal fee patent year 05
13.07.2007Renewal fee patent year 06
14.07.2008Renewal fee patent year 07
10.07.2009Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.10.2009
BE14.10.2009
CY14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
IT14.10.2009
NL14.10.2009
SE14.10.2009
SK14.10.2009
TR14.10.2009
BG14.01.2010
GR15.01.2010
ES25.01.2010
PT15.02.2010
[2012/47]
Former [2012/44]AT14.10.2009
BE14.10.2009
CY14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
IT14.10.2009
NL14.10.2009
SE14.10.2009
SK14.10.2009
BG14.01.2010
GR15.01.2010
ES25.01.2010
PT15.02.2010
Former [2012/37]AT14.10.2009
BE14.10.2009
CY14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
IT14.10.2009
SE14.10.2009
SK14.10.2009
BG14.01.2010
GR15.01.2010
ES25.01.2010
PT15.02.2010
Former [2011/14]AT14.10.2009
BE14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
IT14.10.2009
SE14.10.2009
SK14.10.2009
BG14.01.2010
GR15.01.2010
ES25.01.2010
PT15.02.2010
Former [2010/48]AT14.10.2009
BE14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
SE14.10.2009
SK14.10.2009
BG14.01.2010
GR15.01.2010
ES25.01.2010
PT15.02.2010
Former [2010/39]AT14.10.2009
BE14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
SE14.10.2009
SK14.10.2009
BG14.01.2010
ES25.01.2010
PT15.02.2010
Former [2010/36]AT14.10.2009
BE14.10.2009
CZ14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
SE14.10.2009
BG14.01.2010
ES25.01.2010
PT15.02.2010
Former [2010/35]AT14.10.2009
BE14.10.2009
DK14.10.2009
EE14.10.2009
FI14.10.2009
SE14.10.2009
BG14.01.2010
ES25.01.2010
PT15.02.2010
Former [2010/29]AT14.10.2009
BE14.10.2009
FI14.10.2009
SE14.10.2009
ES25.01.2010
PT15.02.2010
Former [2010/22]FI14.10.2009
SE14.10.2009
ES25.01.2010
PT15.02.2010
Former [2010/19]ES25.01.2010
Documents cited:Search[X]US5981194  (JEFFERIES WILFRED A [CA], et al) [X] 1-6,20-22 * column 8, line 13 - line 30 * * column 8, line 54 - line 67 * * column 14, line 16 - line 20 * * column 25, line 59 - column 26, line 47 * * column 30, line 36 - line 48 ** column 31, line 11 - line 14 *
International search[X]US5981194  (JEFFERIES WILFRED A [CA], et al);
 [XP]WO0159459  (UNIV BRITISH COLUMBIA [CA], et al);
 [XE]US6455494  (JEFFERIES WILFRED A [CA], et al);
 [XP]  - "Biotech Week", (20020619), pages 1 - 3, XP002997368
 [Y]  - QIAN Z.M. ET AL, "Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders", BRAIN RESEARCH REVIEWS, (1998), vol. 27, no. 3, pages 257 - 267, XP001031265

DOI:   http://dx.doi.org/10.1016/S0165-0173(98)00012-5
 [Y]  - FILLEBEEN C. ET AL, "Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier", J BIOL CHEM, (19990312), vol. 274, no. 11, pages 7011 - 7017, XP002997362

DOI:   http://dx.doi.org/10.1074/jbc.274.11.7011
 [Y]  - SHIBATA M. ET AL, "Clearance of Alzheimer's amyloid-beta1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier", J CLIN INVEST, (200012), vol. 106, no. 12, pages 1489 - 1499, XP001077700

DOI:   http://dx.doi.org/10.1172/JCI10498
 [Y]  - SCHULLEK J.R., "A high density screening format for encoded combinatorial libraries: assay miniturization and its application enzymatic reactions", ANALYTICAL BIOCHEMISTRY, (19970301), vol. 246, no. 1, pages 20 - 29, XP002997363

DOI:   http://dx.doi.org/10.1006/abio.1996.9958
by applicantUS3668210
 US3880834
 US3928356
 US3939152
 US3968125
 US3994898
 US4012448
 US4013672
 US4018895
 US4018779
 US4020072
 US4029661
 US4031226
 US4056673
 US4062858
 US4128717
 US4147798
 US4148796
 US4150231
 US4188388
 US4194009
 US4214089
 US4231930
 US4246411
 US4264499
 US4267328
 US4277476
 US4283394
 US4294763
 US4294828
 US4314081
 US4313896
 US4324787
 US4358451
 US4383994
 US4391982
 US4397853
 US4399283
 US4424202
 US4427694
 US4440781
 US4443451
 US4459306
 US4474804
 US4490540
 US4520026
 US4522949
 US4524151
 US4525479
 US4529727
 US4532327
 US4541956
 US4542160
 US4544501
 US4548938
 US4550187
 US4550186
 US4560684
 US4590180
 US4611066
 US4613600
 US4617314
 US4618685
 US4631285
 US4645773
 US4647585
 US4647573
 US4649139
 US4650874
 US4650797
 US4652578
 US4652576
 US4654357
 US4654356
 US4654355
 US4654335
 US4656267
 US4656185
 US4661506
 US4663337
 US4663336
 US4668787
 US4670560
 US4670453
 US4681970
 US4681882
 US4684747
 US4690930
 US4703120
 US4704382
 US4707550
 US4721796
 US4727072
 US4730052
 US4734426
 US4734425
 US4734424
 US4735962
 US4738978
 US4749715
 US4752616
 US4753951
 US4753946
 US4762837
 US4767756
 US4769371
 US4771047
 US4774239
 US4775757
 US4778800
 US4780538
 US4785085
 US4788188
 US4824955
 US4824831
 US4833145
 US4835157
 US4845216
 US4847379
 US4849563
 US4853391
 US4863955
 US4871746
 US4874760
 US4882334
 US4882333
 US4883872
 US4883811
 US4886790
 US4888335
 US4889859
 US4889866
 US4892887
 US4904663
 US4906634
 US4927828
 US4939137
 US4952692
 US4954526
 US4959383
 US4962114
 US4966967
 US4968800
 US4970318
 US4971984
 US4977167
 US4977144
 US4981843
 US4996229
 US4996206
 US5006542
 US5011931
 US5019390
 US5026712
 US5036070
 US5036065
 US5051423
 US5055466
 US5061813
 US5066493
 US5070099
 US5071848
 US5077404
 US5079247
 US5101072
 US5106996
 US5109024
 US5116861
 US5120733
 US5128349
 US5140031
 US5185362
 US5189036
 US5192799
 US5196424
 US5198449
 US5202330
 US5208245
 US5214068
 US5217958
 US5223503
 US5223516
 US5256664
 US5260444
 US5310731
 US5318965
 US5332737
 US5358952
 US5362902
 US5387593
 US5387586
 US5389675
 US5393771
 US5401758
 US5414017
 US5414013
 US5457118
 US5461062
 US5463181
 US5478828
 US5482925
 US5508277
 US5512678
 US5525633
 US5525606
 US5530026
 US5547966
 US5552411
 US5552397
 US5559410
 US5563170
 US5574037
 US5576220
 US5597831
 US5610292
 US5612370
 US5612323
 US5618813
 US5624924
 US5631251
 US5637586
 US5646276
 US5654484
 US5654294
 US5661129
 US5665715
 US5679672
 US5684004
 US5686482
 US5691332
 US5696111
 US5698529
 US5705523
 US5723457
 US5726171
 US5731322
 US5753668
 US5760041
 US5786344
 US5807889
 US5837702
 US5859239
 US5869478
 US5877206
 US5880161
 US5981194
 US2001025026
 US19420002262
 US19540002262
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.